Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15102751
Abstract: Simple Summary Relapsed or refractory (r/r) lymphomas represent hard-to-treat cancers with dismal prognoses. Over the past few years, immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) and programmed cell death ligand 1 (PD-L1)… read more here.
Keywords: novel drugs; drugs radiotherapy; radiotherapy; relapsed lymphomas ... See more keywords